Show simple item record

dc.contributor.authorGRAY, STEVENen
dc.contributor.authorO'BYRNE, KENen
dc.contributor.authorBAIRD, ANNE-MARIEen
dc.date.accessioned2017-01-17T11:24:04Z
dc.date.available2017-01-17T11:24:04Z
dc.date.issued2016en
dc.date.submitted2016en
dc.identifier.citationBaird AM, Gray SG, Richard DJ, O'Byrne KJ, Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model., Scientific reports, 6, 2016, 18907en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractGlobally, lung cancer accounts for approximately 20% of all cancer related deaths. Five-year survival is poor and rates have remained unchanged for the past four decades. There is an urgent need to identify markers of lung carcinogenesis and new targets for therapy. Given the recent successes of immune modulators in cancer therapy and the improved understanding of immune evasion by tumours, we sought to determine the carcinogenic impact of chronic TNF-α and IL-1β exposure in a normal bronchial epithelial cell line model. Following three months of culture in a chronic inflammatory environment under conditions of normoxia and hypoxia (0.5% oxygen), normal cells developed a number of key genotypic and phenotypic alterations. Important cellular features such as the proliferative, adhesive and invasive capacity of the normal cells were significantly amplified. In addition, gene expression profiles were altered in pathways associated with apoptosis, angiogenesis and invasion. The data generated in this study provides support that TNF-α, IL-1β and hypoxia promotes a neoplastic phenotype in normal bronchial epithelial cells. In turn these mediators may be of benefit for biomarker and/or immune-therapy target studies. This project provides an important inflammatory in vitro model for further immuno-oncology studies in the lung cancer setting.en
dc.description.sponsorshipThis work was supported by an unrestricted educational grant from Pfizer (AMB). The HBEC4 cell line was a kind gift from Prof. John D. Minna (Hamon Centre for Therapeutic Oncology Research, UTSouthwestern, Dallas, TX, USA).en
dc.format.extent18907en
dc.relation.ispartofseriesScientific reportsen
dc.relation.ispartofseries6en
dc.rightsYen
dc.subjectlung canceren
dc.subject.lcshlung canceren
dc.titlePromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/graysten
dc.identifier.peoplefinderurlhttp://people.tcd.ie/obyrnekeen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/bairdaen
dc.identifier.rssinternalid111900en
dc.identifier.doihttp://dx.doi.org/10.1038/srep18907en
dc.rights.ecaccessrightsopenAccess
dc.identifier.orcid_id0000-0002-5850-6392en
dc.identifier.urihttp://hdl.handle.net/2262/78762


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record